Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12180843 | PMC |
| http://dx.doi.org/10.1097/CM9.0000000000003583 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Fetal Supraventricular Tachycardia: What Do We Know up to This Day?
J Pers Med
August 2025
1st Department of Cardiology, AHEPA Hospital, School of Medicine, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
Fetal tachyarrhythmias, particularly supraventricular tachycardia (SVT) and atrial flutter (AFL), pose significant clinical challenges, especially when complicated by hydrops fetalis. This article provides a comprehensive review of the tachyarrhythmia types, the diagnostic modalities applied, and the therapeutic strategies followed in fetal tachyarrhythmias. Diagnostic techniques such as M-mode echocardiography and fetal magnetocardiography (fMCG) are highlighted for their capacity to provide real-time, high-quality assessments of fetal cardiac rhythms.
View Article and Find Full Text PDFFetal tachyarrhythmias: current knowledge for clinical practice.
Transl Pediatr
July 2025
Department of Obstetrics, Paulista School of Medicine, Federal University of São Paulo (EPM-UNIFESP), São Paulo, SP, Brazil.
Fetal arrhythmias account for 10-20% of all outpatient consultations in specialized fetal medicine centers. Furthermore, it is evident that tachyarrhythmias account for 8% of all such arrhythmias. Most arrhythmias are benign and easy to manage, but certain tachyarrhythmias require close monitoring due to the risk of decompensation, progression to heart failure with hydrops, and potential fetal death.
View Article and Find Full Text PDFThe maternal exposure of digoxin and flecainide in relation to the safety and effectiveness in the treatment of non-hydropic fetal tachycardia.
Heart Rhythm
May 2025
Department of Clinical Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands; Division of Neonatology, Department of Neonatal and Pediatric Intensive Care, Erasmus University Medical Center - Sophia Children's Hospital, Rotterdam, The Netherlands. Electronic address: r.flint@erasmu
Background: Sustained fetal tachycardia requires transplacental anti-arrhythmic therapy. Little is known about the dose-concentration-effect correlation and safety in the mother, fetus, and newborn.
Objective: This study evaluates the relationship between maternal dose of digoxin and flecainide therapy for fetal tachycardia, maternal and umbilical cord concentrations, and side effects.
Transplacental digoxin treatment for fetal supraventricular arrhythmias: Insights from Chinese fetuses.
Chin Med J (Engl)
June 2025
Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
A case of sustained fetal atrial flutter at 25-week gestation: diagnostic challenges and therapeutic strategies.
Ann Med Surg (Lond)
February 2025
The Internist Cardiologist, Department of Cardiology, Al Watani Hospital, Hama, Syria.
Introduction: Sustained fetal tachycardia is an uncommon phenomenon in gestations (approximately 0.1%). Atrial flutter (AF) accounts for 10-30% of fetal tachyarrhythmias, which is characterized by a rapid atrial rate estimated at 300-600 beats per minute, associated with variable degrees of atrioventricular conduction.
View Article and Find Full Text PDF